Katarina Varnäs

4.4k total citations · 1 hit paper
79 papers, 2.8k citations indexed

About

Katarina Varnäs is a scholar working on Cellular and Molecular Neuroscience, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Katarina Varnäs has authored 79 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cellular and Molecular Neuroscience, 27 papers in Radiology, Nuclear Medicine and Imaging and 25 papers in Molecular Biology. Recurrent topics in Katarina Varnäs's work include Neuroscience and Neuropharmacology Research (24 papers), Neurotransmitter Receptor Influence on Behavior (20 papers) and Receptor Mechanisms and Signaling (20 papers). Katarina Varnäs is often cited by papers focused on Neuroscience and Neuropharmacology Research (24 papers), Neurotransmitter Receptor Influence on Behavior (20 papers) and Receptor Mechanisms and Signaling (20 papers). Katarina Varnäs collaborates with scholars based in Sweden, United States and United Kingdom. Katarina Varnäs's co-authors include Christer Halldin, Håkan Hall, Lars Farde, Peter Johnström, Zsolt Cselényi, Andrea Varrone, Jonas Malmquist, Magnus Schou, Aurelija Jučaitė and Darren A.E. Cross and has published in prestigious journals such as NeuroImage, Brain and Cancer Research.

In The Last Decade

Katarina Varnäs

78 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity

2016 523 citations Peter Ballard, James Yates et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Katarina Varnäs

Since Specialization

Citations

This map shows the geographic impact of Katarina Varnäs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarina Varnäs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarina Varnäs more than expected).

Fields of papers citing papers by Katarina Varnäs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katarina Varnäs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarina Varnäs. The network helps show where Katarina Varnäs may publish in the future.

Co-authorship network of co-authors of Katarina Varnäs

This figure shows the co-authorship network connecting the top 25 collaborators of Katarina Varnäs. A scholar is included among the top collaborators of Katarina Varnäs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarina Varnäs. Katarina Varnäs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Radiosynthesis and Evaluation of 11C-Labeled Isoindolone-Based Positive Allosteric Modulators for Positron Emission Tomography Imaging of Metabotropic Glutamate Receptor 2 2024 ·ACS Pharmacology & Translational Science ·Yinlong Li, Kenneth Dahl, Peter Johnström, Katarina Varnäs, Lars Farde, Christer Halldin, (unknown), Donna L. Maier, Mark Powell, Jiahui Chen, Richard Van, Jimmy S. Patel, (unknown), Yabiao Gao, Zhendong Song, Ahmed Haider, Yihan Shao, Charles S. Elmore, Steven H. Liang, Magnus Schou	0
2	A positron emission tomography study of the serotonin1B receptor effect of electroconvulsive therapy for severe major depressive episodes 2021 ·Journal of Affective Disorders ·Mikael Tiger, (unknown), Amane Tateno, Granville J. Matheson, (unknown), (unknown), (unknown), Katarina Varnäs, Ryosuke Arakawa, Yoshiro Okubo	11
3	Altered striatal dopamine levels in Parkinson’s disease VPS35 D620N mutant transgenic aged mice 2020 ·Molecular Brain ·(unknown), Xiaoxia Zeng, (unknown), Katarina Varnäs, Mei Jiang, Ke Zhang, (unknown), Parasuraman Padmanabhan, Weiping Yu, Zhidong Zhou, Christer Halldin, Balázs Gulyás, Eng‐King Tan, Li Zeng	17
4	In vitro phosphodiesterase 10A (PDE10A) binding in whole hemisphere human brain using the PET radioligand [18F]MNI-659 2019 ·Brain Research ·Marie Svedberg, Katarina Varnäs, Andrea Varrone, Nicholas Mitsios, Jan Mulder, Balázs Gulyás, Vahri Beaumont, Ignacio Muñoz-Sanjuán, Margaret M. Zaleska, Christopher J. Schmidt, Christer Halldin, Ladislav Mrzljak	5
5	The metabotropic glutamate receptor 5 radioligand [11C]AZD9272 identifies unique binding sites in primate brain 2018 ·Neuropharmacology ·Katarina Varnäs, Anders Juréus, Sjoerd J. Finnema, Peter Johnström, Patrick Raboisson, Nahid Amini, Akihiro Takano, В. А. Степанов, Christer Halldin, Lars Farde	12
6	Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity breakdown → 2016 ·Clinical Cancer Research ·Peter Ballard, James Yates, Zhenfan Yang, Dong‐Wan Kim, James Chih‐Hsin Yang, Mireille Cantarini, Kathryn Pickup, Angela Jordan, (unknown), Matthew Grist, Matthew Box, Peter Johnström, Katarina Varnäs, Jonas Malmquist, Kenneth S. Thress, Pasi A. Jänne, Darren A.E. Cross	523
7	Integrated Strategy for Use of Positron Emission Tomography in Nonhuman Primates to Confirm Multitarget Occupancy of Novel Psychotropic Drugs: An Example with AZD3676 2016 ·Journal of Pharmacology and Experimental Therapeutics ·Katarina Varnäs, Anders Juréus, Peter Johnström, (unknown), P.A. Schött, Magnus Schou, Susanne Gruber, Eva Jerning, (unknown), Christer Halldin, Lovisa Afzelius, Lars Farde	4
8	Longitudinal Small-Animal PET Imaging of the zQ175 Mouse Model of Huntington Disease Shows In Vivo Changes of Molecular Targets in the Striatum and Cerebral Cortex 2016 ·Journal of Nuclear Medicine ·Jenny Häggkvist, Miklós Tóth, (unknown), Katarina Varnäs, Marie Svedberg, Anton Forsberg, Sangram Nag, Celia Dominguez, Ignacio Muñoz-Sanjuán, Jonathan Bard, John Wityak, Andrea Varrone, Christer Halldin, Ladislav Mrzljak	14
9	Synthesis, Radiolabeling, and In Vivo Pharmacokinetic Evaluation of the Amyloid Beta Radioligand [11C]AZD4694 in Nonhuman Primates 2013 ·Molecular Imaging and Biology ·Magnus Schou, Katarina Varnäs, Johan Sandell, Peter Johnström, Zsolt Cselényi, Samuel Svensson, Ryuji Nakao, Nahid Amini, (unknown), (unknown), Balázs Gulyás, (unknown), Christer Halldin, Lars Farde	8
10	Modeling of PET data in CNS drug discovery and development 2013 ·Journal of Pharmacokinetics and Pharmacodynamics ·Katarina Varnäs, Andrea Varrone, Lars Farde	29
11	Positron emission tomography imaging of 5-hydroxytryptamine1B receptors in Parkinson's disease 2013 ·Neurobiology of Aging ·Andrea Varrone, Per Svenningsson, Anton Forsberg, Katarina Varnäs, Mikael Tiger, Ryuji Nakao, Christer Halldin, Lars‐Göran Nilsson, Lars Farde	24
12	Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects 2012 ·EJNMMI Research ·Aurelija Jučaitė, Zsolt Cselényi, Annie Arvidsson, Gabrielle Åhlberg, Per Julin, Katarina Varnäs, Per Stenkrona, Jan Andersson, Christer Halldin, Lars Farde	57
13	Radiosynthesis of the candidate β‐amyloid radioligand [¹¹C]AZD2184: Positron emission tomography examination and metabolite analysis in cynomolgus monkeys 2010 ·Synapse ·Jan Andersson, Katarina Varnäs, Zsolt Cselényi, Balázs Gulyás, David Wensbo, Sjoerd J. Finnema, Britt‐Marie Swahn, Samuel Svensson, Svante Nyberg, Lars Farde, Christer Halldin	23
14	Local and covariate-modulated false discovery rates applied in neuroimaging 2009 ·NeuroImage ·Glenn Lawyer, Egil Ferkingstad, Ragnar Nesvåg, Katarina Varnäs, Ingrid Agartz	5
15	Regional thinning of the cerebral cortex in schizophrenia: Effects of diagnosis, age and antipsychotic medication 2008 ·Schizophrenia Research ·Ragnar Nesvåg, Glenn Lawyer, Katarina Varnäs, Anders M. Fjell, Kristine B. Walhovd, Arnoldo Frigessi, Erik G. Jönsson, Ingrid Agartz	172
16	Grey and White Matter Proportional Relationships in the Cerebellar Vermis Altered in Schizophrenia 2008 ·The Cerebellum ·Glenn Lawyer, Ragnar Nesvåg, Katarina Varnäs, Gaku Okugawa, Ingrid Agartz	8
17	Cerebellar volumes in men with schizophrenia and alcohol dependence 2007 ·Psychiatry and Clinical Neurosciences ·Katarina Varnäs, Gaku Okugawa, Anders Hammarberg, Ragnar Nesvåg, Lars M. Rimol, Johan Franck, Ingrid Agartz	15
18	Regional expression of 5-HT_1Breceptor mRNA in the human brain 2005 ·Synapse ·Katarina Varnäs, Yasmin L. Hurd, Håkan Hall	40
19	Synthesis, biological and autoradiographic evaluation of a novel Tc-99m radioligand derived from WAY 100635 with high affinity for the 5-HT1A receptor and the alpha1-adrenergic receptor 2002 ·Nuclear Medicine and Biology ·(unknown), (unknown), Marion Kretzschmar, Katarina Varnäs, Håkan Hall, Christer Halldin, R. Syhre, Werner Kraus, Hans‐Jürgen Pietzsch, Stefan Seifert, Peter Brust, B. Johannsen	27
20	Synthesis and biological evaluation of technetium(III) mixed-ligand complexes with high affinity for the cerebral 5-HT1A receptor and the alpha1-adrenergic receptor 2002 ·Nuclear Medicine and Biology ·(unknown), (unknown), R. Syhre, Stefan Seifert, Katarina Varnäs, Håkan Hall, Christer Halldin, Werner Kraus, Per Karlsson, (unknown), H. Spies, B. Johannsen	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact